Inflammation: the next target for secondary prevention in coronary artery disease

被引：2
|
作者：
Kazi, Samia [1 ,2 ]
Chong, James J. H. [2 ,3 ]
Chow, Clara K. [2 ,3 ]
机构：
[1] Univ Sydney, Westmead Appl Res Ctr, Sydney, NSW, Australia
[2] Westmead Hosp, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2024年 / 220卷 / 03期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
Coronary artery disease; Risk factors; Anti-inflammatory agents; Inflammation; LOW-DOSE COLCHICINE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK;
D O I：
10.5694/mja2.52209
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：115 / 120
页数：6
相关论文
共 50 条
  • [1] Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?
    Cheng, Wan-Hei
    Wang, Ying
    CELLS, 2025, 14 (03)
  • [2] Secondary prevention of coronary artery disease in contemporary clinical practice
    Jankowski, Piotr
    Czarnecka, Danuta
    Wolfshaut-Wolak, Renata
    Lysek, Radoslaw
    Lukaszewska, Anna
    Bogacki, Piotr
    Grodecki, Janusz
    Mirek-Bryniarska, Ewa
    Nessler, Jadwiga
    Podolec, Piotr
    Kawecka-Jaszcz, Kalina
    Pajak, Andrzej
    CARDIOLOGY JOURNAL, 2015, 22 (02) : 219 - 226
  • [3] Secondary Prevention of Coronary Artery Disease
    Hall, Scott L.
    Lorenc, Todd
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (03) : 289 - 296
  • [4] Practice setting and secondary prevention of coronary artery disease
    Jankowski, Piotr
    Czarnecka, Danuta
    Badacz, Leszek
    Bogacki, Piotr
    Dubiel, Jacek S.
    Grodecki, Janusz
    Grodzicki, Tomasz
    Maciejewicz, Janusz
    Mirek-Bryniarska, Ewa
    Nessler, Jadwiga
    Piotrowski, Wieslaw
    Podolec, Piotr
    Smielak-Korombel, Wanda
    Tracz, Wieslawa
    Kawecka-Jaszcz, Kalina
    Pajak, Andrzej
    ARCHIVES OF MEDICAL SCIENCE, 2018, 14 (05) : 979 - 987
  • [5] Canakinumab for secondary prevention of coronary artery disease
    Ortega-Paz, Luis
    Capodanno, Davide
    Angiolillo, Dominick J.
    FUTURE CARDIOLOGY, 2021, 17 (03) : 427 - 442
  • [6] Effects of Olive Oil Phenolic Compounds on Inflammation in the Prevention and Treatment of Coronary Artery Disease
    Lopes de Souza, Priscilla Azambuja
    Marcadenti, Aline
    Portal, Vera Lucia
    NUTRIENTS, 2017, 9 (10)
  • [7] The scientific basis for secondary prevention of coronary artery disease: recent contributions from the Netherlands
    Jorstad, H. T.
    Snaterse, M.
    ter Hoeve, N.
    Sunamura, M.
    Brouwers, R.
    Kemps, H.
    Reimer, W. J. M. Scholte Op
    Peters, R. J. G.
    NETHERLANDS HEART JOURNAL, 2020, 28 (SUPPL 1) : 136 - 140
  • [8] Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey
    Jankowski, Piotr
    Kosior, Dariusz A.
    Sowa, Pawel
    Szostak-Janiak, Karolina
    Koziel, Pawel
    Krzykwa, Agnieszka
    Sawicka, Emilia
    Haberka, Maciej
    Setny, Malgorzata
    Kaminski, Karol
    Gasior, Zbigniew
    Kubica, Aldona
    De Bacquer, Dirk
    De Backer, Guy
    Kotseva, Kornelia
    Wood, David
    Pajak, Andrzej
    Czarnecka, Danuta
    CARDIOLOGY JOURNAL, 2020, 27 (05) : 533 - 540
  • [9] Smartphone-guided secondary prevention for patients with coronary artery disease
    Eckardt, Irina
    Buschhaus, Clara
    Nickenig, Georg
    Jansen, Felix
    JOURNAL OF REHABILITATION AND ASSISTIVE TECHNOLOGIES ENGINEERING, 2021, 8
  • [10] The use of medications in the secondary prevention of coronary artery disease in the Asian region
    Dalal, Jamshed
    Low, Lip-Ping
    Dang Van Phuoc
    Rahman, Abdul Rashid Abdul
    Reyes, Eugenio
    Soenarta, Arieska Ann
    Tomlinson, Brian
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (03) : 423 - 433
12345